The National Cancer Institute (NCI) named Dr. Raymond Osarogiagbon to its board of scientific advisors for a five-year term, beginning immediately and ending June 30, 2027. Dr. Osarogiagbon is the chief scientist at Baptist Memorial Health Care and director of the Multidisciplinary Thoracic Oncology Program and the Thoracic Oncology Research Group at Baptist Cancer Center.
The board of scientific advisors provides advice on scientific program policy and progress, extramural program initiatives and the future direction of NCI’s extramural research programs.
“I am honored to be appointed to NCI’s board of advisors,” said Dr. Osarogiagbon. “This is a testament to the innovative and lifesaving work we’re doing at Baptist and in the Mid-South.”
Dr. Osarogiagbon spearheads Baptist Cancer Center’s Mid-South Miracle initiative, a multifaceted program comprising seven components to help reduce lung cancer deaths in the Mid-South by 25% by 2030. A community oncologist, Dr. Osarogiagbon serves as principal investigator for the Baptist Memorial Health Care/Mid-South Minority/Underserved NCI Community Oncology Research Program (NCORP) and is chair of the board of the Hope Foundation for Cancer Research.
The NCI is the federal government’s principal agency for cancer research and training. NCI leads, conducts and supports cancer research across the nation to advance scientific knowledge and help people live longer, healthier lives.
As the leader of the cancer research enterprise, collectively known as the National Cancer Program, and the largest funder of cancer research in the world, NCI manages a broad range of research, training, and information dissemination activities that reach across the entire country, meeting the needs of all demographics—rich and poor, urban and rural, and all racial/ethnic populations. Specifically, NCI focuses on two broad roles: cancer research and training and support for cancer researchers.
